Bio-Rad Laboratories BIO Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $592.1M-14.6% | $693.2M+6.2% | $653M+0.2% | $651.6M+11.3% | $585.4M-12.3% | ||
| $282.7M-18.8% | $348M+12.4% | $309.6M+1.1% | $306.3M+9.6% | $279.4M-14.2% | ||
| $309.4M-10.4% | $345.2M+0.5% | $343.4M-0.6% | $345.3M+12.8% | $306M-10.5% | ||
| 52.3%+2.5pp | 49.8%-2.8pp | 52.6%-0.4pp | 53%+0.7pp | 52.3%+1.0pp | ||
| $62.9M-10.5% | $70.3M-1.4% | $71.3M+17.9% | $60.5M-17.7% | $73.5M-7.7% | ||
| $212.4M-3.9% | $221M+6.9% | $206.8M-0.4% | $207.7M-0.5% | $208.8M+2.4% | ||
| $15M— | —— | $14.9M+25.2% | $11.9M-22.2% | $15.3M— | ||
| $16.8M— | —— | $16.9M-0.6% | $17M+6.3% | $16M— | ||
| $34.1M— | —— | $65.3M-15.3% | $77.1M+225% | $23.7M-59.3% | ||
| 5.8%— | —— | 10%-1.8pp | 11.8%+7.8pp | 4%-4.7pp | ||
| $12.3M+1.7% | $12.1M-1.6% | $12.3M-2.4% | $12.6M+5.0% | $12M-1.6% | ||
| $21M— | —— | $13.7M-6.8% | $14.7M-59.4% | $36.2M— | ||
| $24.2M-15.4% | $28.6M+245% | $8.3M-48.8% | $16.2M-56.5% | $37.2M+89.8% | ||
| $2.5M— | —— | $1M+11.1% | $900K+80.0% | $500K— | ||
| -$689.8M-174% | $929.2M+316% | -$431.1M-204% | $414M+396% | $83.4M+109% | ||
| -$162.7M-178% | $209.2M+335% | -$89.2M-193% | $96.2M+396% | $19.4M+110% | ||
| -$19.55-174% | $26.39+308% | -$12.70-209% | $11.67+410% | $2.29+109% | ||
| -$19.55-174% | $26.41+308% | -$12.70-209% | $11.67+410% | $2.29+109% | ||
| 27M-1.2% | 27.3M+1.3% | 26.9M-1.1% | 27.2M-2.6% | 28M-0.9% | ||
| 27M-1.1% | 27.3M+1.3% | 26.9M-1.1% | 27.2M-2.6% | 27.9M-1.0% | ||
| —— | $225.1M0.0% | $225.1M0.0% | $225.1M0.0% | $225.1M+134% | ||
| $21M— | —— | $13.7M-6.8% | $14.7M-59.4% | $36.2M— | ||
| -$727.7M— | —— | —— | —— | —— | ||
| $15M— | —— | $14.9M+25.2% | $11.9M-22.2% | $15.3M— | ||
| $100K— | —— | —— | -$600K+40.0% | -$1M— | ||
| $700K— | —— | $1M+150% | $400K0.0% | $400K— | ||
| $5.9M— | —— | $7.3M+40.4% | $5.2M+4.0% | $5M— | ||
| 206K— | —— | 235K-53.4% | 504K+107% | 244K— | ||
| -$3.8M— | —— | $6.2M+294% | -$3.2M-153% | $6M— | ||
| -$23.2M— | —— | —— | -$151.4M-555% | $33.3M— | ||
| -$573.4M— | —— | -$354.6M-162% | $573.5M+198% | $192.4M— | ||
| $5.9M— | —— | —— | -$16.2M-800% | -$1.8M— | ||
| $0.24— | —— | $0.21-10.8% | $0.23-0.4% | $0.23— | ||
| -$8.4M— | —— | $1.8M+175% | -$2.4M-152% | $4.6M— | ||
| $300K— | —— | $300K0.0% | $300K0.0% | $300K— | ||
| $200K— | —— | $200K0.0% | $200K0.0% | $200K— | ||
| $100K— | —— | $100K0.0% | $100K0.0% | $100K— | ||
| $100K— | —— | $100K0.0% | $100K0.0% | $100K— | ||
| $2.4M+14.3% | $2.1M-27.6% | $2.9M+364% | -$1.1M-141% | $2.7M+42.1% | ||
| $5.9M— | —— | —— | -$30.3M-110% | -$14.4M— | ||
| -$2.7M— | —— | —— | $5.1M+24.4% | $4.1M— | ||
| -$2.7M— | —— | —— | $167M+3,973% | $4.1M— | ||
| $11M+50.7% | $7.3M— | $0-100% | $48.2M+510% | $7.9M-66.7% | ||
| $9.6M— | —— | —— | $4.7M-84.2% | $29.8M— | ||
| $166M— | —— | $88.4M+227% | -$69.5M-8,788% | $800K— | ||
| -$10.6M— | —— | -$11.3M+3.4% | -$11.7M-6.4% | -$11M— | ||
| $2M— | —— | -$1M-119% | $5.3M+210% | -$4.8M— | ||
| $0— | —— | $0-100% | $2K-85.7% | $14K— | ||
| $22.4M— | —— | $22.4M+2,389% | $900K-95.9% | $22.2M— | ||
| -$738.2M— | —— | -$495.3M-248% | $334.4M+952% | $31.8M— | ||
| -$44M— | $0+100% | -$52.5M+61.5% | -$136.3M-39.5% | -$97.7M-273% | ||
| -$93.2M-173% | -$34.2M+20.5% | -$43M+62.7% | -$115.4M-4,079% | $2.9M+110% | ||
| $108.1M-34.4% | $164.9M+36.4% | $120.9M+3.8% | $116.5M-10.3% | $129.9M+4.6% | ||
| $1.7M— | —— | $0— | $0— | $0— | ||
| $6M— | —— | $1.8M+38.5% | $1.3M-61.8% | $3.4M— | ||
| $6.6M— | —— | $900K— | —— | $2.7M— | ||
| 2— | —— | —— | —— | —— | ||
| $10.6M— | —— | $11.3M-3.4% | $11.7M+6.4% | $11M— | ||
| $9.7M— | —— | $10M0.0% | $10M-1.0% | $10.1M— | ||
| $500K— | —— | —— | —— | $0— | ||
| $500K— | —— | —— | —— | —— | ||
| $500K— | —— | -$500K-267% | $300K+50.0% | $200K— | ||
| $1.1M— | —— | —— | —— | $0— | ||
| -$40.9M— | —— | -$14.7M-106% | $254.5M+106% | $123.6M— | ||
| -$46.3M— | —— | -$12.7M-105% | $255.7M+99.1% | $128.4M— | ||
| -$46.3M— | —— | -$12.7M-105% | $255.7M+99.1% | $128.4M— | ||
| -$6M— | —— | $1.5M0.0% | $1.5M-70.0% | $5M— | ||
| $40.9M— | —— | $44.2M+8.9% | $40.6M+6.6% | $38.1M— | ||
| $700K— | —— | $1M+66.7% | $600K+20.0% | $500K— | ||
| $24.2M-15.4% | $28.6M+245% | $8.3M-48.8% | $16.2M-56.5% | $37.2M+89.8% | ||
| $47.8M— | $0-100% | $53.4M-61.9% | $140.2M+37.6% | $101.9M— | ||
| $226.1M+62.9% | $138.8M-38.0% | $223.9M+46.1% | $153.2M-0.1% | $153.4M-31.2% | ||
| $30M-34.5% | $45.8M+44.5% | $31.7M-30.6% | $45.7M+32.8% | $34.4M-19.8% | ||
| $515.8M-5.8% | $547.5M+5.8% | $517.5M+2.3% | $505.9M+3.7% | $488M-7.4% | ||
| -$9.9M— | —— | $8.6M-66.9% | $26M+213% | $8.3M— | ||
| $614.1M-12.0% | $697.7M+6.7% | $653.8M-1.7% | $664.9M+3.9% | $640M+1.2% | ||
| $3.4M— | —— | $3.4M-19.0% | $4.2M-2.3% | $4.3M— | ||
| $17.7M+490% | $3M-78.3% | $13.8M-46.3% | $25.7M+31.8% | $19.5M-34.6% | ||
| $33.3M+82.0% | $18.3M+32.6% | $13.8M-57.7% | $32.6M+100% | $16.3M-14.2% | ||
| $145.1M-1.6% | $147.4M-26.5% | $200.6M-26.9% | $274.4M+60.3% | $171.2M-16.7% | ||
| $100K— | —— | —— | $100K— | $0— | ||
| $1.9M— | —— | $1.8M+38.5% | $1.3M-7.1% | $1.4M— | ||
| $2.8M— | —— | $1.9M+138% | $800K-20.0% | $1M— | ||
| $2.5M— | —— | $1M+11.1% | $900K+80.0% | $500K— | ||
| $100K-50.0% | $200K— | $0-100% | $200K+100% | $100K— | ||
| 3%— | —— | 3%0.0% | 3%0.0% | 3%— | ||
| $592.1M— | —— | $653M+0.2% | $651.6M+11.3% | $585.4M— | ||
| $2.3M— | —— | $1.7M-95.5% | $38M+1,710% | $2.1M— | ||
| $3.4M— | —— | —— | $4.2M-2.3% | $4.3M— | ||
| $500K— | —— | $500K-64.3% | $1.4M+40.0% | $1M— | ||
| $47.3M— | —— | $52.9M-61.9% | $138.8M+37.6% | $100.9M— | ||
| $8.8M— | —— | $4M-66.7% | $12M+76.5% | $6.8M— | ||
| -$4.6M— | —— | -$4.4M-650% | $800K+157% | -$1.4M— | ||
| $34.1M-96.4% | $941.3M+1,342% | $65.3M-15.3% | $77.1M+225% | $23.7M-59.3% | ||
| $80.9M— | —— | $116.8M-5.0% | $122.9M+84.0% | $66.8M— | ||
| $80.9M— | —— | $116.8M-5.0% | $122.9M+84.0% | $66.8M— | ||
| 13.7%— | —— | 17.9%-1.0pp | 18.9%+7.5pp | 11.4%— | ||
| $34.1M-96.4% | $941.3M+1,342% | $65.3M-15.3% | $77.1M+225% | $23.7M-59.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Rad Laboratories's revenue?
- Bio-Rad Laboratories (BIO) generated $2.6B in revenue over the trailing twelve months, up 1.9% year over year.
- Is Bio-Rad Laboratories profitable?
- Bio-Rad Laboratories reported $168.8M in net income over the trailing twelve months, a 6.5% net margin.
- What are Bio-Rad Laboratories's profit margins?
- Gross margin is 51.9% and operating margin is 8.8%, with a 6.5% net margin.
- What is Bio-Rad Laboratories's earnings per share?
- Bio-Rad Laboratories's diluted EPS over the trailing twelve months is $5.81.
- Where does Bio-Rad Laboratories's income statement data come from?
- Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
